IMP A SDB — Implantica AG Cashflow Statement
0.000.00%
Last trade - 00:00- SEK33.13bn
- SEK32.40bn
- €1.94m
Annual cashflow statement for Implantica AG, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -10.3 | -15.5 | -21.4 | -24.5 | -23.7 |
| Depreciation | |||||
| Non-Cash Items | -0.218 | 2.38 | 3.73 | 2.63 | -1.58 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1.31 | 0.21 | -0.02 | 0.342 | -0.788 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -10.4 | -11.5 | -16 | -19.9 | -22.8 |
| Capital Expenditures | -1.75 | -5.44 | -9.3 | -3.83 | -0.442 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | — | -46.2 | 50.4 | 0.675 | 0.787 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -1.75 | -51.6 | 41.1 | -3.15 | 0.345 |
| Financing Cash Flow Items | 116 | 55.6 | -0.3 | -0.027 | -0.048 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 109 | 48.1 | -0.937 | -0.431 | -0.305 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 97.5 | -13.2 | 24.6 | -21 | -23.4 |